Search

Displaying results 8961 - 8970 of 10000 in total
  1. Drug

    Atagabalin

    go.drugbank.com/drugs/DB12032
    Investigational

    Atagabalin has been used in trials studying the treatment of Insomnia, Primary Insomnia, and Nonrestorative Sleep.

  2. Drug

    ORM-12741

    go.drugbank.com/drugs/DB12057
    Investigational

    ORM-12741 has been used in trials studying the basic science and treatment of Alzheimer's Disease.

  3. Drug

    ORG-25935

    go.drugbank.com/drugs/DB12220
    Investigational

    Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.

  4. Drug

    Brilanestrant

    go.drugbank.com/drugs/DB12253
    Investigational

    ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.

  5. Drug

    CRS-3123

    go.drugbank.com/drugs/DB12262
    Investigational

    CRS3123 has been used in trials studying the treatment of Clostridial Infection and Clostridium Difficile Colitis.

  6. Drug

    Linrodostat

    go.drugbank.com/drugs/DB14986
    Investigational

    Linrodostat is under investigation in clinical trial NCT03247283 (Pharmacokinetics and Metabolism Study in Healthy Male Participants).

  7. Drug

    Apararenone

    go.drugbank.com/drugs/DB15024
    Investigational

    Apararenone is under investigation in clinical trial NCT02531568 (Drug Interaction Study of Warfarin and MT-3995).

  8. Drug

    Psicose

    go.drugbank.com/drugs/DB15087
    Experimental

    Psicose is under investigation in clinical trial NCT02459834 (The Fructose and Allulose Catalytic Effects (FACE) Trial).

  9. Drug

    GLPG-0259

    go.drugbank.com/drugs/DB15190
    Investigational

    GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).

  10. Drug

    Seletalisib

    go.drugbank.com/drugs/DB12706
    Investigational

    Seletalisib has been used in trials studying the treatment and basic science of Primary Sjogren's Syndrome.